Tyler M. Thompson

Senior Advisor

Washington, D.C.
T +1.202.861.1571
F +1.202.861.1783

Overview

Tyler Thompson assists clients with healthcare issues related to children's hospitals, as well as policies related to access to affordable pharmaceuticals and other healthcare matters. His knowledge and experience stems from previously held positions within the governmental and healthcare areas, having previously served as lead consultant to clients throughout the healthcare industry and holding positions in the United States Senate for more than 10 years, focusing in the area of healthcare policy. Through this work, Tyler forged strong relationships with key members and staff in House and Senate leadership, as well as relevant committees of jurisdiction in both chambers. Believing that strong communication skills and an understanding of issues are the keys to effective government affairs representation, Tyler works thoughtfully in a bipartisan manner to bridge gaps between opposing viewpoints. This strategy, along with his knowledge of current healthcare concerns and insight into legislative procedures, provides mutual benefits to lawmakers and clients.

*[Not an Attorney]

Select Experience

  • Worked to reform policy related to children's healthcare needs through involvement in the Children’s Hospital Graduate Medical Education Reauthorization policy.
  • Navigated policies and procedures while providing substantive work and strategic analysis of the Affordable Care Act for a key US Senator.
  • Collaborated with opposing viewpoints during discussions on the Hope Offered Through Principled and Ethical Stem Cell Research (HOPE) Act. Used strong communication to assist in development of policies that addressed interests of all parties on controversial topic.
More »

Experience

  • Worked to reform policy related to children's healthcare needs through involvement in the Children’s Hospital Graduate Medical Education Reauthorization policy.
  • Navigated policies and procedures while providing substantive work and strategic analysis of the Affordable Care Act for a key US Senator.
  • Collaborated with opposing viewpoints during discussions on the Hope Offered Through Principled and Ethical Stem Cell Research (HOPE) Act. Used strong communication to assist in development of policies that addressed interests of all parties on controversial topic.
  • Negotiated and compromised with opposing parties throughout development of the Drug Quality of Security Act.
  • Involved in development of legislative policies related to pharmaceutical and medical device industry, including the Prescription Drug User Fee Act, Medical Device User Fee Act, Animal Drug User Fee Act, Biologics Price and Competition Act, Pandemic and All-Hazards Preparedness Act, and Medicare Modernization Act. Used combined knowledge of policies and politics at play to advance specific interests while remaining sensitive to stances of opposing parties.
  • Advised Senators and healthcare industry client on healthcare regulations and policies within the Department of Health and Human Services. Provided additional advice on healthcare issues concerning, among other things, CDC and NIH budget formulation and appropriations and OMB policy.

Recognitions and Memberships

Services

Industries

Prior Positions

  • The Bockorny Group: Principal and Healthcare Practice Lead (2012 to 2013)
  • Legislative Assistant for United States Senator Johnny Isakson (2005 to 2012)
  • Legislative Correspondent for United States Senator Saxby Chambliss (2005)
  • Legislative Correspondent for United States Senator Zell Miller (2002 to 2005)

Admissions

  • [Not an Attorney]

Education

  • B.A., History, Sewanee: The University of the South, 2002

Blog

In The Blogs

Previous Next
Ohio Clock
Senate Bill Would Force Company Cyber Disclosure on SEC Filings
By Peggy A. Peterson
March 19, 2019
Amid growing alarm on Capitol Hill over cybersecurity and data privacy, new Senate legislation would require publicly traded companies to disclose in Securities and Exchange Commission (SEC) filings whether they have cybersecurity experts...
Read More ->
Ohio Clock
The Weekly Hill Update - March 11, 2019
By Adam J. Higgins
March 11, 2019
Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES • The Trump administration will release its fiscal year 2020 budget request, a largely symbolic document that demonstrates the...
Read More ->
Ohio Clock
Capitol Hill Healthcare Update - March 11, 2019
By Christian B. Jones
March 11, 2019
Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Azar testifies before three committees on HHS’ budget; a series of Senate bills targeting pharma...
Read More ->
Ohio Clock
Four Things to Know: What the Election Results Mean for Trade Policy
By Tyler M. Thompson
November 13, 2018
Democrats’ new majority in the House will bring the Trump administration’s past trade actions, as well as those under consideration, into sharper focus. Trade is shaping up to be a key issue heading into the 2020 election cycle, with...
Read More ->
Ohio Clock
Medicaid Expansion Boon to Families, but Cost Could Trigger Backlash
By Tyler M. Thompson
June 26, 2018
Earlier this month, Virginia became the 33rd state to expand its Medicaid program, and voters in Idaho, Montana and Utah are expected to decide in November ballot initiatives whether to join them. Medicaid provides health coverage to...
Read More ->